DAWN FAIRBURN: Open Payments
NPI 1316353055 · BAINBRIDGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 28 payments from 16 companies in 2025. Trend: 2023 $508 · 2024 $413 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $132 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Astellas Pharma US Inc | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| ABBVIE INC. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Ozempic, REXULTI, Wegovy, Veozah, Kerendia, MOUNJARO, VOQUEZNA, GEMTESA.
Industry payments across IN — which companies pay providers there.
